Peripheral modifications of [Ψ[CH 2 NH]Tpg 4 ]vancomycin with added synergistic mechanisms of action provide durable and potent antibiotics
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peripheral modifications of [Ψ[CH
2
NH]Tpg
4
]vancomycin with added synergistic mechanisms of action provide durable and potent antibiotics
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume -, Issue -, Pages 201704125
Publisher
Proceedings of the National Academy of Sciences
Online
2017-05-31
DOI
10.1073/pnas.1704125114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The drug-resistant bacteria that pose the greatest health threats
- (2017) Cassandra Willyard NATURE
- Regulatory Incentives for Antibiotic Drug Development: A Review of Recent Proposals
- (2016) Michael S. Sinha et al. BIOORGANIC & MEDICINAL CHEMISTRY
- SEDS proteins are a widespread family of bacterial cell wall polymerases
- (2016) Alexander J. Meeske et al. NATURE
- Antibacterial drug discovery in the resistance era
- (2016) Eric D. Brown et al. NATURE
- Total Syntheses and Initial Evaluation of [Ψ[C(═S)NH]Tpg4]vancomycin, [Ψ[C(═NH)NH]Tpg4]vancomycin, [Ψ[CH2NH]Tpg4]vancomycin, and Their (4-Chlorobiphenyl)methyl Derivatives: Synergistic Binding Pocket and Peripheral Modifications for the Glycopeptide Antibiotics
- (2015) Akinori Okano et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Solving the Antibiotic Crisis
- (2015) Gerard D. Wright ACS Infectious Diseases
- Oritavancin: First Global Approval
- (2014) Anthony Markham DRUGS
- Membrane Active Vancomycin Analogues: A Strategy to Combat Bacterial Resistance
- (2014) Venkateswarlu Yarlagadda et al. JOURNAL OF MEDICINAL CHEMISTRY
- Total Synthesis of [Ψ[C(═NH)NH]Tpg4]Vancomycin and its (4-Chlorobiphenyl)methyl Derivative: Impact of Peripheral Modifications on Vancomycin Analogues Redesigned for Dual d-Ala-d-Ala and d-Ala-d-Lac Binding
- (2014) Akinori Okano et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Momentum builds around new antibiotic business models
- (2014) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Enzymatic Glycosylation of Vancomycin Aglycon: Completion of a Total Synthesis of Vancomycin and N- and C-Terminus Substituent Effects of the Aglycon Substrate
- (2014) Atsushi Nakayama et al. ORGANIC LETTERS
- Antibiotic effectiveness: Balancing conservation against innovation
- (2014) R. Laxminarayan SCIENCE
- Redesign of Glycopeptide Antibiotics: Back to the Future
- (2012) Robert C. James et al. ACS Chemical Biology
- Silver(I)-Promoted Conversion of Thioamides to Amidines: Divergent Synthesis of a Key Series of Vancomycin Aglycon Residue 4 Amidines That Clarify Binding Behavior to Model Ligands
- (2012) Akinori Okano et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The rise of the Enterococcus: beyond vancomycin resistance
- (2012) Cesar A. Arias et al. NATURE REVIEWS MICROBIOLOGY
- Antibiotic resistance is ancient: implications for drug discovery
- (2012) Gerard D. Wright et al. TRENDS IN MICROBIOLOGY
- Molecular mechanisms of antibiotic resistance
- (2011) Gerard D. Wright CHEMICAL COMMUNICATIONS
- A Redesigned Vancomycin Engineered for Duald-Ala-d-Ala andd-Ala-d-Lac Binding Exhibits Potent Antimicrobial Activity Against Vancomycin-Resistant Bacteria
- (2011) Jian Xie et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Total Synthesis of [Ψ[C(═S)NH]Tpg4]Vancomycin Aglycon, [Ψ[C(═NH)NH]Tpg4]Vancomycin Aglycon, and Related Key Compounds: Reengineering Vancomycin for Dual d-Ala-d-Ala and d-Ala-d-Lac Binding
- (2011) Jian Xie et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Antibiotic resistance is ancient
- (2011) Vanessa M. D’Costa et al. NATURE
- Mobile genetic elements and their contribution to the emergence of antimicrobial resistant Enterococcus faecalis and Enterococcus faecium
- (2010) K. Hegstad et al. CLINICAL MICROBIOLOGY AND INFECTION
- New Lipoglycopeptides
- (2010) George G. Zhanel et al. DRUGS
- The antibiotics market
- (2010) Bashar Hamad NATURE REVIEWS DRUG DISCOVERY
- Telavancin
- (2009) G. Ralph Corey et al. NATURE REVIEWS DRUG DISCOVERY
- Dalbavancin
- (2008) Vanessa R Anderson et al. DRUGS
- Linezolid (ZYVOX), the First Member of a Completely New Class of Antibacterial Agents for Treatment of Serious Gram-Positive Infections
- (2008) Steven J. Brickner et al. JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now